Elon Musk's Neuralink receives Canadian approval for brain chip trial
Reuters
Elon Musk's Neuralink announced it has received approval to conduct its first clinical trial in Canada for a brain implant designed to enable paralysed individuals to operate digital devices through thought.
The study, conducted at Toronto's University Health Network hospital, will evaluate the implant's safety and functionality for individuals with quadriplegia. Health Canada has not commented on the approval.
Neuralink has already implanted the device in two U.S. patients, with one using it successfully for tasks like playing video games and 3D design.
Founded in 2016, the company is developing brain chip interfaces to aid disabled individuals in movement, communication, and vision restoration. In September, it received FDA "breakthrough device" status for its vision-restoring implant.
15:42
Reykjanes Peninsula Eruptions: A Timeline of Volcanic Activity Since 2021
Iceland’s Reykjanes Peninsula, active again after 800 years, has seen repeated volcanic eruptions since 2021. From lava fountains to massive fissures, eruptions have reshaped the landscape, attracting tourists while prompting evacuations and safety warnings.
What is your opinion on this topic?
Leave the first comment